Concert Pharmaceuticals Inc. (CNCE) gained 7.37% or 1.55 to $22.59. It is nearly 658683 shares traded, which is 178.76% compare to the average total volume 368470. The market cap of CNCE is $514.43 million. The year to date change is -22.73%. The 52 week price range is from $9.45 to $30.71. Price of CNCE have changed -3.26% during last week. It have changed 2.83% over last month, -11.78% over last 3 months, 39.15% over last 6 months and 121.24% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CNCE is 22.92. It is 1.46% above current price. The 200-day Moving Averages for CNCE is 17.63. It is -21.96% below current price. The 52-week High is 30.71. It is 35.95% from the current price. The 52-week Low is 9.45. It is -58.17% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of CNCE is 2.71 on 2018-02-15. Short % to float is 5.22%. There are some statistics of CNCE. It is has market cap $514.43 million. The share outstanding is 22.77 million. The average volume is 368470. The revenue is 143.90M. The percent of top 15 Institution holding is 65.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CNCE is 61.41%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CNCE is 55.25%.